MX9207541A - Aparato para suministro de dispersion de droga conliberacion controlada. - Google Patents

Aparato para suministro de dispersion de droga conliberacion controlada.

Info

Publication number
MX9207541A
MX9207541A MX9207541A MX9207541A MX9207541A MX 9207541 A MX9207541 A MX 9207541A MX 9207541 A MX9207541 A MX 9207541A MX 9207541 A MX9207541 A MX 9207541A MX 9207541 A MX9207541 A MX 9207541A
Authority
MX
Mexico
Prior art keywords
hydration
dispersion
drug
supply
controlled release
Prior art date
Application number
MX9207541A
Other languages
English (en)
Inventor
Gerald S Rork
James D Pipkin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of MX9207541A publication Critical patent/MX9207541A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Electrotherapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un aparato para suministro controlado de un agente benéfico como una dispersión gelatinosa que consiste de (i) un núcleo que contiene un agente benéfico, un polímero que forma partículas microscópicas gelatinosas ante hidratación y si se desea un agente para modula hidratación de polímero; y (ii) un revestimiento insoluble impermeable que se adhiere a y circunde el núcleo y contiene aberturas que proporcionan un área de la hidratación y libera una dispersión que comprende partículas microscópicas gelatinosas.
MX9207541A 1991-12-27 1992-12-23 Aparato para suministro de dispersion de droga conliberacion controlada. MX9207541A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81530491A 1991-12-27 1991-12-27
US90218892A 1992-07-29 1992-07-29

Publications (1)

Publication Number Publication Date
MX9207541A true MX9207541A (es) 1994-06-30

Family

ID=27123932

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9207541A MX9207541A (es) 1991-12-27 1992-12-23 Aparato para suministro de dispersion de droga conliberacion controlada.

Country Status (26)

Country Link
EP (1) EP0549331B1 (es)
JP (1) JPH089534B2 (es)
KR (1) KR100281609B1 (es)
CN (1) CN1074368A (es)
AT (1) ATE157001T1 (es)
AU (1) AU660057B2 (es)
BG (1) BG61751B1 (es)
CA (1) CA2085871C (es)
CZ (1) CZ284045B6 (es)
DE (1) DE69221711T2 (es)
DK (1) DK0549331T3 (es)
ES (1) ES2106838T3 (es)
FI (1) FI109451B (es)
GR (1) GR3024885T3 (es)
HU (1) HU219594B (es)
IL (1) IL104189A (es)
LV (1) LV12082B (es)
MX (1) MX9207541A (es)
NO (1) NO310672B1 (es)
NZ (1) NZ245514A (es)
PL (1) PL171110B1 (es)
RO (1) RO112810B1 (es)
RU (1) RU2127586C1 (es)
SK (1) SK279964B6 (es)
WO (1) WO1993012765A1 (es)
YU (1) YU48762B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
KR100503266B1 (ko) * 1997-01-14 2005-07-25 에르테에스 로만 테라피-시스테메 게엠베하 운트 코. 카게 위장관 내의 활성물질 방출을 조절하는, 팽창가능한 위장 체류성 치료장치
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6506397B1 (en) * 1999-02-19 2003-01-14 Curt Thies Pest controlling
AU3957400A (en) 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
US6861071B2 (en) 2000-08-08 2005-03-01 Daiichi Pharmaceutical Co., Ltd. Highly absorptive solid preparation
PL362687A1 (en) 2001-01-12 2004-11-02 Sun Pharmaceutical Industries Limited Spaced drug delivery system
US20030153617A1 (en) * 2001-12-18 2003-08-14 Dalen Frans Van Simvastatin dosage forms
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
AU2002351739A1 (en) * 2001-12-18 2003-06-30 Novo Nordisk A/S Solid dose micro implant
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
WO2004028510A1 (en) * 2002-09-28 2004-04-08 Mcneil-Ppc, Inc. Delayed release dosage forms
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
JP2008504938A (ja) 2004-07-02 2008-02-21 レイザー，エリオット 治療媒体送出装置およびその送出装置を用いて治療媒体を眼に送り出す方法
SG170816A1 (en) 2006-03-31 2011-05-30 Qlt Plug Delivery Inc Drug delivery methods, structures, and compositions for nasolacrimal system
CN101861135A (zh) 2007-09-07 2010-10-13 Qlt栓塞输送公司 泪道植入物检测
CA2846384C (en) 2011-08-29 2020-12-15 Qlt Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
JP2020066606A (ja) * 2018-10-25 2020-04-30 株式会社ダイセル １型ヘルパーｔ細胞増加剤、食品、及び医薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin

Also Published As

Publication number Publication date
FI109451B (fi) 2002-08-15
CA2085871A1 (en) 1993-06-28
GR3024885T3 (en) 1998-01-30
IL104189A0 (en) 1993-05-13
LV12082A (lv) 1998-07-20
KR100281609B1 (ko) 2001-02-15
EP0549331A1 (en) 1993-06-30
NO942430D0 (no) 1994-06-27
HUT70437A (en) 1995-10-30
BG61751B1 (bg) 1998-05-29
RO112810B1 (ro) 1998-01-30
ATE157001T1 (de) 1997-09-15
RU2127586C1 (ru) 1999-03-20
FI943011A (fi) 1994-06-22
CN1074368A (zh) 1993-07-21
CA2085871C (en) 2002-05-07
WO1993012765A1 (en) 1993-07-08
KR940703653A (ko) 1994-12-12
YU111292A (sh) 1995-12-04
SK279964B6 (sk) 1999-06-11
CZ284045B6 (cs) 1998-07-15
EP0549331B1 (en) 1997-08-20
RU94031474A (ru) 1997-04-20
FI943011A0 (fi) 1994-06-22
JPH089534B2 (ja) 1996-01-31
ES2106838T3 (es) 1997-11-16
NZ245514A (en) 1994-12-22
DK0549331T3 (da) 1997-09-15
DE69221711D1 (de) 1997-09-25
NO310672B1 (no) 2001-08-13
BG98805A (bg) 1995-03-31
IL104189A (en) 1996-10-31
SK76994A3 (en) 1995-05-10
AU3034892A (en) 1993-08-12
CZ157094A3 (en) 1994-12-15
HU219594B (hu) 2001-05-28
LV12082B (en) 1998-09-20
PL171110B1 (pl) 1997-03-28
YU48762B (en) 1999-11-22
NO942430L (no) 1994-06-27
HU9401913D0 (en) 1994-09-28
JPH05255071A (ja) 1993-10-05
AU660057B2 (en) 1995-06-08
DE69221711T2 (de) 1998-03-12

Similar Documents

Publication Publication Date Title
MX9207541A (es) Aparato para suministro de dispersion de droga conliberacion controlada.
PL320792A1 (en) Applicator for controllably releasing a drug suspension
ATE177325T1 (de) Transdermales system
DK0954245T3 (da) Ultralydsafgivelsessystem til terapeutisk anvendelse
DE69431247D1 (de) Oxybutyninformulierungen mit gesteuerter freisetzung
ES545679A0 (es) Procedimiento para producir un comprimido de dispensacion de un principio biologicamente activo.
ES2093271T3 (es) Recubrimiento polimerico.
DE69407404T2 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
NO931859L (no) Blanding for kontrollert frigjoering av en aktiv bestanddel
CA2222359A1 (fr) Composition cosmetique comprenant l'association d'un polymere filmogene et d'une dispersion de cire et utilisation de ladite association
AU7267191A (en) Method for coating active principles with a ph-sensitive polymer
FI101855B1 (fi) Menetelmä asetatsolamidia jatkuvasti vapauttavan asetatsolamidivalmisteen valmistamiseksi
EP1058156A3 (en) Integrating waveguide for use in lithographic projection apparatus
YU47887B (sh) Postupak za pravljenje čvrstog farmaceutskog preparata za oslobadjanje aktivne supstance
EP0296567A3 (en) Exposure device

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees